Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Antitumor Agents 288: Design, Synthesis, SAR, And Biological Studies Of Novel Heteroatom-incorporated Antofine And Cryptopleurine Analogues As Potent And Selective Antitumor Agents.

X. Yang, Q. Shi, S. Yang, C. Chen, Sung-Liang Yu, K. Bastow, S. Morris-Natschke, P. Wu, Chin-Yu Lai, Tian-Shung Wu, Shiow-Lin Pan, Che-Ming Teng, Jau-Chen Lin, P. Yang, K. Lee
Published 2011 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Novel heteroatom-incorporated antofine and cryptopleurine analogues were designed, synthesized, and tested against a panel of five cancer cell lines. Two new S-13-oxo analogues (11 and 16) exhibited potent cell growth inhibition in vitro (GI(50): 9 nM and 20 nM). Interestingly, both compounds displayed improved selectivity among different cancer cell lines, in contrast to the natural products antofine and cryptopleurine. Mechanism of action (MOA) studies suggested that R-antofine promotes dysregulation of DNA replication during early S phase, while no similar effects were observed for 11 and 15 on corresponding replication initiation complexes. Compound 11 also showed greatly reduced cytotoxicity against normal cells and moderate antitumor activity against HT-29 human colorectal adenocarcinoma xenograft in mice without overt toxicity.
This paper references
10.1021/BI00633A026
Mutants of CHO cells resistant to the protein synthesis inhibitors, cryptopleurine and tylocrebrine: genetic and biochemical evidence for common site of action of emetine, cryptopleurine, tylocrebine, and tubulosine.
R. Gupta (1977)
Inhibition of thymidylate synthase by pergularinine, tylophorinidine and deoxytubulosine.
K. N. Rao (1999)
10.1016/S1359-6446(03)02827-7
In silico prediction of blood-brain barrier permeation.
D. Clark (2003)
10.1016/S0009-2797(97)00065-3
Inhibition of thymidylate synthase and cell growth by the phenanthroindolizidine alkaloids pergularinine and tylophorinidine.
K. N. Rao (1997)
10.1124/MOL.105.017764
Anti-Inflammatory Mechanisms of Phenanthroindolizidine Alkaloids
C. Yang (2006)
10.1016/J.BBRC.2007.01.065
Anti-inflammatory effects of 7-methoxycryptopleurine and structure-activity relations of phenanthroindolizidines and phenanthroquinolizidines.
C. Yang (2007)
10.1016/J.BMCL.2007.11.054
Structural analogs of tylophora alkaloids may not be functional analogs.
W. Gao (2008)
10.1021/NP060081Y
Phenanthroquinolizidine alkaloids from the roots of Boehmeria pannosa potently inhibit hypoxia-inducible factor-1 in AGS human gastric cancer cells.
Xing Fu Cai (2006)
10.1016/S0887-2333(99)00092-2
Inhibition of dihydrofolate reductase and cell growth activity by the phenanthroindolizidine alkaloids pergularinine and tylophorinidine: the in vitro cytotoxicity of these plant alkaloids and their potential as antimicrobial and anticancer agents.
K. N. Rao (2000)
10.1055/S-2001-18703
Isolation, Total Synthesis and Biological Activity of Phenanthroindolizidine and Phenanthroquinolizidine Alkaloids
Z. Li (2004)
10.1602/neurorx.2.4.554
Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery
M. Alavijeh (2011)
10.1021/JM061366A
Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
L. Wei (2007)
10.2174/157340709787580928
Phenanthroindolizidines and Phenanthroquinolizidines: Promising Alkaloids for Anti-Cancer Therapy.
S. Chemler (2009)
10.1016/J.BMCL.2006.05.059
The interaction between tylophorine B and TMV RNA.
Z. Xi (2006)
10.1016/0031-9422(90)80209-Y
An antimicrobial alkaloid fromFicus septica
B. Baumgartner (1990)
Structural determinants responsible for the biological activity of (-)-emetine, (-)-cryptopleurine, and (-)-tylocrebrine: structure-activity relationship among related compounds.
R. Gupta (1980)
10.3109/10611869808997889
Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors.
H. van de Waterbeemd (1998)
10.1021/jm9009263
Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agents.
X. Yang (2009)
10.1021/jm801344j
Phenanthrene-based tylophorine-1 (PBT-1) inhibits lung cancer cell growth through the Akt and NF-kappaB pathways.
Jau-Chen Lin (2009)
10.1016/J.BMCL.2007.05.021
Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents.
W. Gao (2007)
10.2174/157017808784872106
Efficient Synthesis of Aza-Phenanthroindolizidine and Aza-Phenanthroquinolizidine and Anticancer Activities
K. Wang (2008)
10.1016/J.BMCL.2005.09.032
C8c-C15 monoseco-analogues of the phenanthroquinolizidine alkaloids julandine and cryptopleurine exhibiting potent anti-angiogenic properties.
M. Banwell (2006)
10.1055/S-2006-962803
Plant based antiamoebic drugs; Part I. Antiamoebic activity of phenanthroindolizidine alkaloids; common structural determinants of activity with emetine.
K. Bhutani (1987)
10.1371/journal.pone.0011607
DCB-3503, a Tylophorine Analog, Inhibits Protein Synthesis through a Novel Mechanism
Y. Wang (2010)
Mode of action of tylocrebrine: effects on protein and nucleic acid synthesis.
M. Huang (1972)
Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation.
J. Cusack (2000)
10.1021/jf902543r
Synthesis and antiviral activities of phenanthroindolizidine alkaloids and their derivatives.
K. Wang (2010)
10.1158/0008-5472.CAN-03-1904
Novel Mode of Action of Tylophorine Analogs as Antitumor Compounds
W. Gao (2004)
10.1021/ol902819j
Antitumor agents. 274. A new synthetic strategy for E-ring SAR study of antofine and cryptopleurine analogues.
X. Yang (2010)
10.1021/BI00256A023
Quantitation of the specific interaction of [14a-3H]cryptopleurine with 80S and 40S ribosomal species from the yeast Saccharomyces cerevisiae.
H. Dölz (1982)
Anticancer agents based on natural product models
J. M. Cassady (1980)
10.1021/NP50019A005
The Indolizidine Alkaloids
E. Gellert (1982)



This paper is referenced by
10.1016/j.bmc.2012.07.044
Synthesis and evaluation of the anti-proliferative and NF-κB activities of a library of simplified tylophorine analogs.
M. J. Niphakis (2012)
10.2174/1568026613666131213154633
Synthesis of alkaloids: recent advances in the synthesis of phenanthroindolizidine alkaloids.
A. Burtoloso (2014)
10.1016/j.bmcl.2012.03.109
Synthesis of indolizidinone analogues of cytotoxic alkaloids: monocyclic precursors are also active.
A. Boto (2012)
10.1016/j.bmc.2017.12.027
Structure-activity relationships of cryptopleurine analogs with E-ring modifications as anti-hepatitis C virus agents
Y. Wang (2018)
10.1371/journal.pone.0051138
Cryptopleurine Analogs with Modification of E Ring Exhibit Different Mechanism to Rac-Cryptopleurine and Tylophorine
Y. Wang (2012)
10.1016/j.ejmech.2012.02.048
Synthesis and SAR studies of phenanthroindolizidine and phenanthroquinolizidine alkaloids as potent anti-tumor agents.
Ziwen Wang (2012)
10.1002/EJOC.201800908
The Reactivity of Enantiopure (S)‐6‐Oxopipecolic Acid and Corresponding Pyridoisoquinolines Under Acidic Conditions
P. Šafár̆ (2018)
10.1016/j.neuro.2013.02.001
Antofine-induced connexin43 gap junction disassembly in rat astrocytes involves protein kinase Cβ.
Y. Huang (2013)
10.1021/jm3001218
Antitumor agents 295. E-ring hydroxylated antofine and cryptopleurine analogues as antiproliferative agents: design, synthesis, and mechanistic studies.
X. Yang (2012)
10.1021/acs.jmedchem.5b00764
Design, Synthesis, and Biological Activity of Sulfonamide Analogues of Antofine and Cryptopleurine as Potent and Orally Active Antitumor Agents.
Yongseok Kwon (2015)
10.1016/B978-0-08-096805-6.00016-4
Seven-Membered Rings
J. H. Ryan (2011)
10.1021/ol4025925
Total synthesis of phenanthroindolizidine alkaloids through an amidyl radical cascade/rearrangement reaction.
G. Han (2013)
10.2174/1570180811666141009235124
First Discovery of Tylophora Alkaloids as HIV Inhibitors
Ziwen Wang (2015)
10.1016/j.bmc.2018.02.050
Sulfamic acid promoted one-pot synthesis of phenanthrene fused-dihydrodibenzo-quinolinones: Anticancer activity, tubulin polymerization inhibition and apoptosis inducing studies.
N. P. Kumar (2018)
10.1021/jf304905k
Synthesis and antiviral activities of antofine analogues with different C-6 substituent groups.
M. Wu (2013)
10.1016/j.ejmech.2017.01.001
Synthesis of 2,3,6,7-tetramethoxyphenanthren-9-amine: An efficient precursor to access new 4-aza-2,3-dihydropyridophenanthrenes as apoptosis inducing agents.
N. P. Kumar (2017)
10.1016/j.bmcl.2017.04.022
Design and synthesis of 1,2,3-triazolo-phenanthrene hybrids as cytotoxic agents.
N. P. Kumar (2017)
10.1002/cbic.201200313
Antofine Analogues Can Inhibit Tobacco Mosaic Virus Assembly through Small‐Molecule–RNA Interactions
S. Gao (2012)
10.1016/j.ejmech.2017.09.006
Synthesis of substituted phenanthrene-9-benzimidazole conjugates: Cytotoxicity evaluation and apoptosis inducing studies.
N. P. Kumar (2017)
10.1016/j.tet.2016.04.047
Use of chiral-pool approach into epi-thieno analogues of the scarce bioactive phenanthroquinolizidine alkaloids
P. Šafár̆ (2016)
10.1016/j.ejmech.2013.06.009
Simplification of antitumoral phenanthroindolizidine alkaloids: short synthesis of cytotoxic indolizidinone and pyrrolidine analogs.
J. Miguélez (2013)
10.1016/j.jchromb.2013.01.024
Optimization of on-line solid phase extraction and HPLC conditions using response surface methodology for determination of WM-5 in mouse plasma and its application to pharmacokinetic study.
L. Liu (2013)
10.1038/s41419-018-1139-z
A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy
Wenda Zhang (2018)
10.1016/j.ejmech.2018.03.069
Microwave-assisted one-pot synthesis of new phenanthrene fused-tetrahydrodibenzo-acridinones as potential cytotoxic and apoptosis inducing agents.
N. P. Kumar (2018)
10.1016/j.ejmech.2020.112516
Design, synthesis and antitumour evaluation of pyrrolo[1,2-f]-phenanthridine and dibenzo[f,h]pyrrolo[1,2-b]isoquinoline derivatives.
Anilkumar S. Patel (2020)
10.1517/17460441.2015.1018174
The use of natural products in colorectal cancer drug discovery
K. Miura (2015)
10.2174/1574892815666200131120618
Alkaloids as Anticancer Agents: A Review of Chinese Patents in Recent 5 Years.
Hongyu Tao (2020)
10.1016/j.bmc.2012.11.039
Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity.
Yongseok Kwon (2013)
10.1002/tcr.201900027
Reliability of Click Chemistry on Drug Discovery: A Personal Account.
N. Shankaraiah (2019)
Semantic Scholar Logo Some data provided by SemanticScholar